[Clinical aspects of immune pathological studies in pemphigoid and Duhring's herpetiform dermatitis].
D000906:Antibodies; D001485:Basement Membrane; D003165:Complement System Proteins; D003874:Dermatitis Herpetiformis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D003937:Diagnosis, Differential; D005455:Fluorescent Antibody Technique; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D011537:Pruritus; D012008:Recurrence; D012871:Skin Diseases / Q000175:diagnosis / Q000276:immunology*; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D013449:Sulfonamides; D013450:Sulfones; D003165:Complement System Proteins
Klinische Aspekte der immunopathologischen Untersuchungen bei Pemphigoid und Dermatitis herpetiformis Duhring.